Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Q&A: Cardiologist Fatima Rodriguez on the AHA’s COVID-19 patient data registry

Back in April, the American Heart Association launched a new patient data registry to learn more about COVID-19 and its associations with cardiovascular disease. We reached out to the AHA for an update on that registry's progress. 

Hydroxychloroquine, azithromycin linked to “potentially lethal” cardiovascular complications

Hydroxychloroquine and azithromycin are both associated with significant cardiovascular complications, and taking them together could be a deadly combination, according to new research published in Circulation.

Thumbnail

North Dakota has the best health infrastructure during the COVID-19 pandemic

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

Thumbnail

Heart transplants provide value for patients with AL, ATTR cardiac amyloidosis

With the disease becoming more and more common in the United States, researchers have been hard at work determining the best possible treatment options.

Thumbnail

‘Do-not-resuscitate’ orders for COVID-19 patients?

New findings highlight why a blanket “do-not-resuscitate” order for COVID-19 patients is not needed. 

Thumbnail

Selatogrel provides heart attack patients with a lightning-fast antiplatelet response

A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

Thumbnail

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020. 

Thumbnail

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.